Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Aspen Aerogels, Inc. Reports Fourth Quarter 2014 and Fiscal 2014 Financial Results


      News provided by

      Aspen Aerogels, Inc.

      Feb 26, 2015, 04:05 ET

      Share this article

      Share this article


      NORTHBOROUGH, Mass., Feb. 26, 2015 /PRNewswire/ -- Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen Aerogels") today announced financial results for its fourth quarter of 2014 and full year 2014, which ended December 31, 2014, and discussed business highlights from the quarter.

      Total revenue for the quarter of $28.0 million reflected growth of 15% compared to the fourth quarter last year.  On a GAAP basis, fourth quarter net loss was $2.7 million compared to a net loss of $17.0 million in the fourth quarter of 2013. GAAP net loss attributable to common stockholders per share ("GAAP EPS") for the fourth quarter was $0.12 compared to $5,403.25 in the fourth quarter of 2013.

      Total revenue for the year of $102.4 million reflected growth of 19% compared to last year.  On a GAAP basis, annual net loss in 2014 was $66.3 million, or $5.37 per share, which included a total of $38.8 million of non-cash expenses recorded in connection with the completion of the initial public offering on June 18, 2014, including (i) accretion of convertible notes to final conversion value, and (ii) recognition of compensation cost of performance-based stock options.  

      Adjusted EBITDA for the fourth quarter was $1.3 million, compared to $0.2 million in the fourth quarter of 2013. Adjusted EBITDA for 2014 was $3.0 million, compared to Adjusted EBITDA of $(1.8) million in 2013.  A reconciliation of GAAP to non-GAAP results is provided in the financial schedules that are part of this press release. An explanation of these measures is also included below under the heading "Non-GAAP Financial Measures."

      Fourth Quarter 2014 Highlights

      • Record revenue of $28.0 million
      • Record gross profit of $5.2 million
      • Record Adjusted EBITDA of $1.3 million
      • Seven consecutive quarters of positive Adjusted EBITDA
      • Positive quarterly cash flow from operations of $4.7 million

      "The year 2014 was an important one for Aspen Aerogels. We completed our IPO in June 2014, which provided funds needed to expand our capacity to meet growing customer demand and significantly strengthened our balance sheet. The construction of our third manufacturing line in East Providence, RI, remains on schedule, and we expect to have this line operational during the second quarter of 2015.  Our second manufacturing plant remains on track to begin operations in 2017, and we have narrowed the list to a few specific locations in the United States. We will announce the site location upon completion of certain strategic negotiations related to raw material supply, government incentives and financing," said Don Young, President and CEO of Aspen Aerogels. 

      "Aspen Aerogels also achieved several important financial milestones during 2014, including significant improvements in profitability as measured by gross margin, gross profit and Adjusted EBITDA. The health of our business remains strong and I am excited about our prospects for 2015," continued Don Young, President and CEO of Aspen Aerogels.

      2015 Financial Outlook
      Aspen Aerogels updates its 2015 full year outlook as follows:

      • Total revenue is expected to range between $113 million and $117 million, unchanged from prior guidance
      • Adjusted EBITDA is expected to range between $8.5 million and $10.5 million, unchanged from prior guidance
      • GAAP EPS is expected to range between $(0.24) and $(0.36) per share, an increase from prior guidance of $(0.31) to $(0.43) per share

      Our 2015 outlook assumes depreciation and amortization of between $10.0 million and $10.5 million, stock based compensation of between $5.7 million and $6.0 million, interest expense of $0.2 million, and weighted average shares of common stock outstanding of 23 million for the full year. Our outlook also assumes that our third manufacturing line in East Providence, RI, will be operational at the beginning of the second quarter of 2015 with output ramping at a rate during the remainder of 2015 that ensures that we maintain safe and efficient operations.

      We expect quarterly revenue and Adjusted EBITDA to improve significantly throughout 2015 due to increasing output from line three. We expect revenue to ramp from a range of $23 million to $25 million in the first quarter to a range of $30 million to $32 million in the fourth quarter. We expect Adjusted EBITDA to ramp from a range of $0 to $1 million in the first quarter to a range of $4 million to $5 million in the fourth quarter.

      Aspen Aerogels may incur charges, realize gains or losses, or experience other events in 2015 that could cause actual results to vary from this outlook. In addition, the timing of projects may have a significant impact on quarterly and annual revenue and profitability and can be difficult to predict.

      Conference Call Notification
      A conference call with Aspen Aerogels management to discuss the fourth quarter results and business highlights will be webcast at 5:00 pm ET on February 26, 2015. During the call, management will respond to questions concerning, but not limited to, Aspen Aerogels' financial performance, business conditions and industry outlook. Management's discussion and responses could contain information that has not been previously disclosed. The conference call will be available live as a listen-only webcast and will be hosted at the Investors section of the Aspen Aerogels website, www.aerogel.com. In addition, you may call 877-201-0168 (toll free, U.S. & Canada only), passcode "59077296", or 647-788-4901, passcode "59077296", to listen to the live webcast.

      Following the live event, an archived version of the webcast will be available on the Aspen Aerogels website for convenient on-demand replay.

      A copy of this press release is posted in the Investors section on the Aspen Aerogels website.

      Non-GAAP Financial Measures
      In addition to providing financial measurements based on generally accepted accounting principles in the United States of America ("GAAP"), Aspen Aerogels provides additional financial metrics that are not prepared in accordance with GAAP ("non-GAAP").  These non-GAAP financial measures include Adjusted EBITDA.  Management uses these non-GAAP financial measures, in addition to GAAP financial measures, as a measure of operating performance because the non-GAAP financial measures do not include the impact of items that management does not consider indicative of Aspen Aerogels' core operating performance.  In addition, management uses Adjusted EBITDA (i) for planning purposes, including the preparation of Aspen Aerogels' annual operating budget, (ii) to allocate resources to enhance the financial performance of our business, and (iii) as a performance measure under our bonus plan.

      Management believes that these non-GAAP financial measures reflect Aspen Aerogels' ongoing business in a manner that allows for meaningful comparisons and analysis of trends in its business, as they exclude expenses and gains not reflective of Aspen Aerogels' ongoing operating results or that may be infrequent and/or unusual in nature. Management also believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating Aspen Aerogels' operating results and future prospects in the same manner as management and in comparing financial results across accounting periods and to those of peer companies. These non-GAAP measures may not be comparable to similarly titled measures presented by other companies.

      The non-GAAP financial measures do not replace the presentation of Aspen Aerogels' GAAP financial results and should only be used as a supplement to, not as a substitute for, Aspen Aerogels' financial results presented in accordance with GAAP. In this press release, Aspen Aerogels has provided a reconciliation of each non-GAAP financial measure used in its financial reporting to the most directly comparable GAAP financial measure. Management strongly encourages investors to review Aspen Aerogels' financial statements and publicly-filed reports in their entirety and not rely on any single measure.

      About Aspen Aerogels, Inc.
      Aspen Aerogels is an energy technology company that designs, develops and manufactures innovative, high-performance aerogel insulation used primarily in large-scale energy infrastructure facilities. Headquartered in Northborough, Mass., Aspen Aerogels manufactures its Cryogel®, Pyrogel® and Spaceloft® products at its facility in East Providence, R.I.

      Special Note Regarding Forward-Looking and Cautionary Statements
      This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements, including statements relating to Aspen Aerogels' 2015 Financial Outlook. These statements are not historical facts but rather are based on Aspen Aerogels' current expectations, estimates and projections regarding Aspen Aerogels' business, operations and other factors relating thereto, including with respect to the 2015 Financial Outlook. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates," "outlook,"  and similar expressions are used to identify these forward-looking statements. Such forward-looking statements include statements regarding, among other things, Aspen Aerogels' expectations about revenue, expenses, Adjusted EBITDA and GAAP EPS; beliefs about the general health of Aspen Aerogels' business; accounting assumptions involved in arriving at the expectations, and expectations about when Aspen Aerogels' third manufacturing line and second plant will become operational.  All such forward-looking statements are based on management's present expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, the following: any disruption in either of our two production lines or the manufacturing facility in which they are located;  inability to achieve expected capacity levels of our third production line; any failure to achieve an increase in production capacity that Aspen Aerogels' growth requires in a timely manner; any failure of demand for Aspen Aerogels' products; the failure to obtain significant additional capital to pursue Aspen Aerogels' growth strategy beyond construction of Aspen Aerogels' third production line; the failure of our products to become widely adopted; the competition Aspen Aerogels faces in its business; the failure to manage Aspen Aerogels' growth, and the demands that growth places on Aspen Aerogels' management systems and infrastructure; any failure of Aspen Aerogels' products to meet applicable specifications and technical and delivery requirements; the general economic conditions and cyclical demands in the markets that Aspen Aerogels serves; any sustained downturn in the energy industry and/or energy prices; the economic, operational and political risks associated with sales and expansion of operations in foreign countries; the loss of any direct customer, including contractors and OEMs; compliance with health and safety laws and regulations; shortages of raw materials; the maintenance and development of distribution channels; and the other risk factors discussed under the heading "Risk Factors" contained in our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2014 and filed with the Securities and Exchange Commission ("SEC")  on November 7, 2014, as well as any updates to those risk factors filed from time to time in our subsequent periodic and current reports filed with the SEC. All statements contained in this press release are made only as of the date of this press release, and Aspen Aerogels does not intend to update this information unless required by law.

      ASPEN AEROGELS, INC.

      Condensed Consolidated Balance Sheets

      (In thousands, except share and per share data)








      December 31


      December 31



      2014


      2013






      Assets



      Current assets:





      Cash and cash equivalents


      $        49,719


      $          1,574

      Accounts receivable, net of allowances


      17,924


      18,762

      Inventories


      4,897


      6,892

      Prepaid expenses and other current assets


      836


      791

      Total current assets


      73,376


      28,019

      Property, plant, and equipment, net


      71,492


      62,023

      Other assets


      175


      191

      Total assets


      $      145,043


      $        90,233






      Liabilities and Stockholders' (Deficit) Equity



      Current liabilities:





      Subordinated notes, current portion


      $                   -


      $        17,306

      Convertible notes, current portion


      -


      435

      Capital leases, current portion


      76


      75

      Revolving line of credit


      -


      1,000

      Accounts payable


      14,202


      7,114

      Accrued expenses


      5,588


      4,814

      Deferred revenue


      292


      595

      Other current liabilities


      50


      50

      Total current liabilities


      20,208


      31,389

      Senior convertible notes


      -


      28,135

      Convertible notes, excluding current portion


      -


      91,439

      Capital leases, excluding current portion


      89


      165

      Other long-term liabilities


      1,030


      1,071

      Total liabilities


      21,327


      152,199






      Stockholders' (deficit) equity:





      Additional paid-in capital


      522,800


      270,794

      Accumulated deficit


      (399,084)


      (332,760)

      Total stockholders' equity (deficit)


      123,716


      (61,966)

      Total liabilities and stockholders' equity (deficit)


      $      145,043


      $        90,233

      ASPEN AEROGELS, INC.

      Consolidated Statements of Operations
















      Three months ended
      December 31


      Twelve months ended
      December 31




      2014


      2013


      2014


      2013




      (In thousands, except
      share and per share data)


      (In thousands, except
      share and per share data)











      Revenues:










      Product



      $       27,284


      $      23,253


      $       99,259


      $  82,057

      Research services



      700


      979


      3,140


      4,037

      Total revenue



      27,984


      24,232


      102,399


      86,094

      Cost of revenue:










      Product



      22,361


      20,143


      83,677


      73,399

      Research services



      387


      506


      1,642


      1,964

      Gross profit



      5,236


      3,583


      17,080


      10,731

      Operating expenses:










      Research and development



      1,519


      1,358


      5,980


      5,159

      Sales and marketing



      2,418


      2,287


      10,290


      9,271

      General and administrative



      3,958


      3,142


      16,853


      12,833

      Write-off of construction in process



      -


      3,440


      -


      3,440

      Total operating expenses



      7,895


      10,227


      33,123


      30,703

      Income (loss) from operations



      (2,659)


      (6,644)


      (16,043)


      (19,972)

      Other income (expense):










      Interest expense



      (56)


      (10,306)


      (50,281)


      (30,599)

      Gain on extinguishment of convertible notes



      -


      -


      -


      8,898

      Loss on exchange of convertible notes



      -


      -


      -


      (5,697)

      Costs associated with postponed public offering



      -


      -


      -


      (241)

      Total other income (expense), net



      (56)


      (10,306)


      (50,281)


      (27,639)

      Net income (loss)



      $       (2,715)


      $    (16,950)


      $     (66,324)


      $ (47,611)

      Net income (loss) attributable to common stockholders:



      $       (2,715)


      $    (16,950)


      $     (66,324)


      $     1,338











      Net income (loss) attributable to common stockholders per common share:










      Basic



      $          (0.12)


      $ (5,403.25)


      $          (5.37)


      $  426.52

      Diluted



      $          (0.12)


      $ (5,403.25)


      $          (5.37)


      $  410.56

      Weighted-average common shares outstanding:










      Basic



      22,992,273


      3,137


      12,349,456


      3,137

      Diluted



      22,992,273


      3,137


      12,349,456


      3,259

          

      Aspen Aerogels, Inc.

      Square Foot Operating Metric
      We price our product and measure our product shipments in square feet.



      Three Months Ended


      Twelve Months Ended



      December 31,


      December 31,



      2014


      2013


      2014


      2013



      (amounts in square feet in thousands)

      Product shipments in square feet


      9,976


      10,247


      38,222


      35,560

      Reconciliation of Non-GAAP Financial Measures  
      The following table presents a reconciliation of the non-GAAP financial measure included in the Aspen Aerogels, Inc. press release dated February 26, 2015 to the most directly comparable GAAP measure:

      Reconciliation of Net Income (Loss) to Adjusted EBITDA
      We define Adjusted EBITDA as net income (loss) before interest expense, taxes, depreciation, amortization, stock-based compensation expense and other items, from time to time, that we do not believe are indicative of our core operating performance, which recently have included loss on disposal of assets, gain or loss on extinguishment or exchange of debt, costs of postponed financing activities and the write-off of construction in progress.











      Reconciliation of Net Income (loss) to Adjusted EBITDA














      Three Months Ended


      Twelve Months Ended




      December 31,


      December 31,




      2014


      2013


      2014


      2013




      (amounts in thousands)











      Net income (loss)

      $         (2,715)


      $       (16,950)


      $       (66,324)


      $       (47,611)


      Interest expense

      56


      10,306


      50,281


      30,599


      Depreciation and amortization

      2,492


      2,630


      10,183


      10,061


      Loss on disposal of assets

      104


      230


      119


      230


      Stock-based compensation

      1,382


      505


      8,781


      4,426


      Gain on extinguishment of convertible notes

      -


      -


      -


      (8,898)


      Loss on exchange of convertible notes

      -


      -


      -


      5,697


      Costs associated with postponed public









      offering

      -


      -


      -


      241


      Write-off of construction in progress

      -


      3,440


      -


      3,440













      Adjusted EBITDA

      $          1,319


      $             161


      $          3,040


      $         (1,815)

      SOURCE Aspen Aerogels, Inc.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.